Thu, Dec 25, 2014, 5:22 PM EST - U.S. Markets closed for Christmas

Recent

% | $
Quotes you view appear here for quick access.

Idera Pharmaceuticals, Inc. Message Board

  • medtrust2 medtrust2 Nov 18, 2013 5:05 PM Flag

    Link between IDRA and PCYC? Perhaps the reason Baker Bros are interested?

    Interesting that Baker Bros was one of the earliest and largest holders of Pharmacyclics, and now they appear to be doing the same with Idera. PCYC's superstar Imbruvica targets Mantle Cell Lymphoma, and Idera's lead candidate IMO-8400 targets Lymphoma as well. Perhaps, just perhaps, Baker Bros sees IDRA as the next PCYC. Looks like trial activity in this area for Idera will be spinning up shortly. Thoughts from other Idera longs?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Baker Bros have a good history in evaluating potential pharma companies , there staff have excellent reputation in evaluating science , and not speculation , their latest investments in IDERA , and further increases in position have defenitly a valid reason

    • I hate to rain on everyone's party, but the Baker Brothers are known for being pumpers and dumpers. They specialize in buying millions of shares of small biotechs, announcing they bought the shares, and selling them quickly after the run up.

      They were one of the top hedge funds last years (15% return) and none of their picks were held very long. They made massive profits by selling into the rallies. They are not investors, they are profiteers.

      I would very much be willing to bet my hat they have gone round trip in IDRA, which explains the ride to 3, and the abrupt journey back to 1.87.

      Of course, you don't have to take my word for it. You could call IDRA shareholder relations and ask directly.

      Sentiment: Hold

 
IDRA
3.89+0.02(+0.52%)Dec 24 12:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yahoo! Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST